Pfizer Inc. is nearly free of government investigations now that it has settled Protonix (pantoprazole) off-label marketing claims for $55 million. But it has yet to resolve claims of illegal Protonix pricing that could have a heftier price tag.
The Department of Justice announced on Dec. 12 that Pfizer had settled a criminal investigation in which the government alleged that Wyeth, which Pfizer acquired in October 2009, promoted...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?